Compare · ACCD vs VENA
ACCD vs VENA
Side-by-side comparison of Accolade Inc. (ACCD) and Venus Acquisition Corporation (VENA): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while VENA operates in Finance - the two are in different parts of the market.
- ACCD is the larger of the two at $1.18B, about 19.3x VENA ($61.0M).
- ACCD has more recent analyst coverage (25 ratings vs 0 for VENA).
- Company
- Accolade Inc.
- Venus Acquisition Corporation
- Price
- $7.03+0.00%
- $10.50-4.81%
- Market cap
- $1.18B
- $61.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2021
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Venus Acquisition Corporation
Venus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, and business combination with one or more businesses. The company was incorporated in 2018 and is based in New York, New York.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest VENA
- SEC Form 6-K filed by Venus Acquisition Corporation
- SEC Form 424B5 filed by Venus Acquisition Corporation
- SEC Form SC 13D/A filed by Venus Acquisition Corporation (Amendment)
- SEC Form 6-K filed by Venus Acquisition Corporation
- SEC Form 424B5 filed by Venus Acquisition Corporation
- SEC Form EFFECT filed by Venus Acquisition Corporation
- SEC Form F-3 filed by Venus Acquisition Corporation
- SEC Form S-8 filed by Venus Acquisition Corporation
- SEC Form 6-K filed by Venus Acquisition Corporation
- SEC Form 6-K filed by Venus Acquisition Corporation